Investor Relations


**New** OCT White Paper reports results from a retrospective, quantitative assessment of reoperation rates among patients in the surgeon’s practice who underwent OCT imaging during breast conserving surgery.

For comprehensive results and additional information, please refer to the full white paper here. Perimeter Medical Imaging AI intends the sharing of this research and associated data for an investor audience and not for use by healthcare professionals. The data collected have not undergone peer review nor evaluation by FDA and should not be used to guide clinical practice.

Company Overview

About Perimeter Medical Imaging AI, Inc.

Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation, artificial intelligence technology that is currently under clinical development. The company’s ticker symbol “PINK” is a reference to the pink ribbons used during Breast Cancer Awareness Month.

Investor Contact Information


Perimeter Medical Imaging
555 Richmond St W
Suite 511
Toronto, ON M5V 3B1
Toll-Free: (888) 988-7465 (PINK)
T: (214) 845-5154
F: (972) 587-7795

Transfer Agent

P.O. Box 43078
Providence, RI 02940

Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.